Gastric fundus submucosa as a site for islets transplantation: An experimental study

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Citação
ANNALS OF MEDICINE AND SURGERY, v.28, p.1-5, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Islets of Langerhans transplantation is a promising alternative for glycemic control in patients with type 1 diabetes. The graft site is a factor that has large impact on the functioning of this transplant, and the stomach appears to be a promising location. Our objective is to describe a new experimental model for the grafting of Islets of Langerhans in rat stomachs. Methodology: Islets of Langerhans were extracted from 45 isogenic male rats of the Lewis lineage and transplanted into 9 isogenic rats of the Wistar lineage; 5 in the gastric body submucosa, and 4 in the gastric fundus submucosa. Normoglycemia was defined as two successive measurements of < 250 mg/dL. No immunosuppression was used. The two groups glycemia control improvement were compared with t-student test. Results: The results obtained following the transplantation of the islets in 9 rats showed between 995 and 2310 islets transplanted (mean of 1367). The rats from the gastric submucosa group had a better glycemic level improvement, with a confidence equal to 83.94%. Conclusion: Islets graft into the gastric fundus submucosa is a viable model with potential for adequate glycemic control. This model gives potential for new perspectives and future studies in this area.
Palavras-chave
Gastric fundus submucosa, Islets transplantation, Type 1 diabetes
Referências
  1. Caiazzo R, 2007, TRANSPL P, V39, P2620, DOI 10.1016/j.transproceed.2007.08.015
  2. Cantarelli E, 2011, CURR DIABETES REP, V11, P364, DOI 10.1007/s11892-011-0216-9
  3. Delfino Vinicius D.A., 2002, Arq Bras Endocrinol Metab, V46, P177, DOI 10.1590/S0004-27302002000200011
  4. Echeverria GJ, 2009, AM J TRANSPLANT, V9, P2485, DOI 10.1111/j.1600-6143.2009.02815.x
  5. Farney AC, 2016, PANCREAS, V45, P8, DOI 10.1097/MPA.0000000000000391
  6. International Diabetes Federation. IDF. 2015, 2015, IDF DIABETES ATLAS
  7. Iuamoto LR, 2017, CLINICS, V72, P238, DOI 10.6061/clinics/2017(04)08
  8. Iuamoto LR, 2014, WORLD J GASTROENTERO, V20, P13512, DOI 10.3748/wjg.v20.i37.13512
  9. Janssen P., 2011, PHARMACOL THERAPEUT, V33, P880
  10. Liu XN, 2014, ANN TRANSPL, V19, P331, DOI 10.12659/AOT.890744
  11. Rajab A, 2010, CURR DIABETES REP, V10, P332, DOI 10.1007/s11892-010-0130-6
  12. Wszola M, 2009, ANN TRANSPL, V14, P45